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The authors describe the deposition of single biomolecules on substrates at deﬁned spacing by pure
self-assembly. The substrate is equipped with an array of 8 nm large gold particles which form the
template for biomolecule binding. The authors veriﬁed the successful binding of single
biomolecules via speciﬁc antibody labeling and imaging by ﬂuorescence microscopy. Scanning
force microscopy provided evidence that every gold nanoparticle of the pattern is occupied by at
least one biomolecule. Furthermore, gold conjugated secondary antibodies in combination with
scanning electron microscopy proved that at least 75% of the nanoparticles carried only one active
biomolecule. The precision given by such surface densities is molecularly deﬁned and such
considerably higher than in any other case reported so far. © 2007 American Vacuum
Society. DOI: 10.1116/1.2713991
I. INTRODUCTION
Immobilization of biomolecules on glass cover slips by a
variety of methods is widely applied in cell biology consid-
ering the study of cellular responses on surfaces presenting
biomolecules.1 Available surface functionalization methods
lack a proper control of the amount of proteins which is
immobilized to the surface on the scale of single proteins,
i.e., presenting protein surface concentrations with molecular
precision. In general, global biomolecule surface densities
are evaluated by, e.g., x-ray photoelectron spectroscopy, in-
frared spectroscopy, UV-visible absorption, ﬂuorescence in-
tensity, or radioactive labeling. However, global protein sur-
face density lacks information on molecule-to-molecule
distance. In order to consider functions given by multivalent
interactions between proteins,2 it is of great importance not
only to control the global but molecularly deﬁned surface
density, i.e., protein-protein spacing. In particular, cell signal
transduction due to receptor clustering is drastically affected
by molecularly deﬁned surface densities.3,4
As well as density, orientation of biomolecules at inter-
faces also inﬂuences the activity of biofunctionalized inter-
faces. Orientation of proteins according to their N and C
terminus is realized by a variety of tags such as biotin, cys-
teine, or histidine tag His tag.5 Conventional streptavidin or
avidin presents four binding sites for biotin and therefore
lacks the possibility to immobilize single biotin conjugated
proteins.6,7 Recently, a monovalent streptavidin-biotin sys-
tem was reported.8 The binding state of biotin-streptavidin
cannot be easily regulated and displays a rather strong afﬁn-
ity. Metal-coordinating groups such as nitrilotriacetic acid9–11
NTA allow immobilization of single proteins with His tag
by Ni2+ chelators. Its binding state is regulated by ethylene-
diamine tetra-acetic acid or other chelating agents. This sys-
tem has a KD of 10−13 which displays a higher binding ac-
tivity than most monoclonal antibodies and other tag
systems.12,13 Binding strength is enhanced by multivalent
binding concepts14 and TACN-tag systems,15 offering much
stronger afﬁnities than conventional NTA. However, once
immobilized on homogeneous surfaces all of these systems
lack an appropriate spatial control, i.e., spacing of individual
molecules at interfaces.
Laterally conﬁned molecule presentation at interfaces was
limited to submicrometer patches, due to technological
limitations.9 Even smaller two-dimensional structures with
100 nm feature sizes could be prepared by nanoimprint
lithography.16 By developing micellar nanolithography, this
resolution limit was reduced to structures 10 nm. So far,
only small peptides were immobilized on those substrates.3,4
Peptides alone can induce certain cell biological relevant
processes, such as focal adhesions.3 Even more complex re-
cruitment processes in the cell membrane such as in choles-
terol enriched domains17 and synapses18 desire the activation
through proteins in deﬁned pattern. However, addressing
questions in cell biology with respect to molecular spacing
generates an important need for deﬁned nanostructured sur-
faces which are capable to accept only a single molecule at
an individual binding site in a deﬁned orientation.19,20
II. EXPERIMENT
For protein immobilization studies quasihexagonally ar-
ranged gold nanopatterns on glass surfaces were prepared as
described previously in Ref. 3. Gold nanoparticles had a di-
ameter of approximately 6 nm and a lateral spacing of 30,
96, or 160 nm. To prevent nonspeciﬁc protein interactions
with glass, a monomolecular ﬁlm of mPEG-triethoxysilanes
were covalently bound to the glass surface. The hydrophilic
glass or silicon substrates were inserted for 16–20 h in a
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ﬂask containing a 0.25 mM toluene p.a., dried over molecu-
lar sieve; pore size: 3 Å, EMD mPEG2000-urea solution.
After adding 2.5 M triethylamine EMD the ﬂask was
heated to 80 °C. All chemicals were stored and processed
under inert gas atmosphere of either nitrogen quality 5.0 or
argon quality 5.0 Advantage Gases, Bangor, USA. In or-
der to remove the physisorbed polyethyleneglycol PEG
residues, the samples were rinsed with ethyl acetate p.a.,
EMD and treated for 2 min in an ultrasound bath, where
after samples were again rinsed with ethyl acetate. In a ﬁnal
step, the samples were rinsed with methanol p.a., EMD,
dried under a nitrogen stream, and directly used for the sub-
sequent coupling of biomolecules to the gold nanoparticles.
Then, gold nanopatterns were functionalized by mono-NTA-
thiols Prochimia. A stock solution of NTA was diluted to a
1 mM working solution in p.a. ethanol and incubated for 4 h.
After washing with HBSS, NiCl2 was applied on surfaces.
After two additional washing steps biomolecules R&D sys-
tems, as schematically shown in Fig. 1a, were immobi-
lized to NTA-Ni2+ complexes.
NTA-thiol functionalized gold dot nanostructures were in-
cubated overnight at 4 °C with 1 g/ml proteins in phos-
phate buffer solution PBS, pH 7.4. After brief washing with
PBS, bound proteins were incubated with monoclonal anti-
bodies mouse antiagrin, Stressgen; mouse anti-N-cadherin,
Abcam; mouse anti-L1, Cymbus Biotechnology. All bound
primary mouse antibodies were stained with secondary anti-
mouse conjugated with the ﬂuorescent molecule TRITC
Sigma. Samples were examined with a DMRE microscope
Leica and a 20, 0.7 numerical aperture, air PL APO ob-
jective. Images were acquired with a Micromax Princeton
Instruments camera and METAMORPH imaging software
Universal Imaging. Experiments were repeated three times.
Gold nanopattern functionalized with and without
N-cadherin are analyzed by scanning force SF microscopy
XE100 AFM, PSIA Corp., Korea after drying the substrates
in nitrogen gas ﬂow. Rotated monolithic silicone tips with
symmetric shape and a 30 nm aluminum reﬂex coating Bud-
getSensors, Bulgaria, which have a length 450 m and a
width of 50 m with a tip radius 10 nm, were utilized.
Measurements were taken in contact mode in air under stan-
dard conditions room temperature: 1013 mbars. Three in-
dependent experiments were performed for each substrate.
In order to prove the functionality and the number of im-
mobilized biomolecules per single gold nanoparticle, scan-
ning electron microscopy Zeiss Ultra in combination with
speciﬁc immunogold labeling of antibodies was applied. We
prepared gold nanoparticle substrates with a 96±12 nm spac-
ing on silicon wafer and biofunctionalized these structures
with agrin or N-cadherin. Substrates were incubated for 2 h
at room temperature with monoclonal primary antibodies.
Ideally, one monoclonal antibody recognizes one binding site
per biomolecule. Agrin itself is a monomer offering only one
binding site while N-cadherin is a homodimer offering two
binding sites. Substrates with monoclonal antibodies were
incubated for 1 h at room temperature with gold conjugated
secondary antibodies Jackson ImmunoResearch. After sec-
ondary antibody incubation, substrates were washed in PBS
and ﬁnally in water. Finally, samples were blow dried with
nitrogen and sputter coated BAL-TEC with a carbon layer.
Experiments were repeated three times and for statistical
analysis, 830 gold dots for agrin and 1041 for N-cadherin
were counted.
III. RESULTS AND DISCUSSION
In this study we present a technology for the positioning
of single genetically engineered biomolecules in nanopat-
terns at interfaces such as glass cover slips and demonstrate a
molecularly deﬁned biomolecule density. Figure 1a pre-
sents the principle experimental concept. Nanostructured
gold dot patterns were prepared by micellar diblock copoly-
mer lithography as described previously.21,22 It results in the
organization of individual gold nanoclusters with a deﬁned
and controllable diameter between 1 and 15 nm and lateral
spacing between 15 and 250 nm at surfaces by dip coating.
Each gold cluster represents a size which makes it a candi-
date for potentially only immobilizing a single molecule. The
lateral spacing between individual gold nanoclusters spans
molecularly relevant distances which are also found in pro-
tein clusters in cell membranes. Nonspeciﬁc binding of mol-
FIG. 1. a Scheme of the gold nanopattern and biomolecule presentation at
a surface; b biomolecules used in this study: N-cadherin, L1, and agrin are
all expressed with a His tag; c mono-NTA-thiol linker.
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ecules or proteins to glass cover slips decorated with gold
nanopattern is limited by the so-called passivation of the
gold free surface area with PEG.3 Three different biomol-
ecules were used in this study Fig. 1b. L1 is a member of
the immunoglobulin superfamily Ig-SF and is predomi-
nantly expressed in neuronal tissue, mediating cell-cell
adhesion.23 Agrin is a heparan sulfate proteoglycan and is
expressed in a variety of different tissues and cell types play-
ing different roles in cellular differentiation.24 N-cadherin is
a classical type I cadherin and among other functions medi-
ates calcium dependent cell-cell adhesion in organisms.25 All
three biomolecules are expressed as transmembrane proteins.
The biomolecules used in this study compromise the extra-
cellular domain for L1, N-cadherin, and the very C-terminal
sequence for agrin. L1 and N-cadherin form homodimeric
molecules due to an expression sequence of a part of a hu-
man IgG1 antibody in the recombinant protein. Furthermore,
all biomolecules were expressed as 6-histidine tagged fu-
sion proteins. Agrin is labeled by a His tag at the N terminus,
while L1 and N-cadherin expressed the His tag at the C
terminus. This tag allows a site directed bioconjugation to
the nanogold dots since these are functionalized by mono-
thiol NTA linker Prochimia, Fig. 1c. This only allows
binding of L1 and N-cadherin via the C terminus and agrin
via the N terminus to the gold dot surface by NTA-Ni2+
chelators. This orientation resembles the natural orientation
of these proteins in the cell membrane.
The protein immobilization on nanopatterned areas could
be conﬁrmed on a global scale by ﬂuorescent secondary an-
tibodies that bind to the corresponding monoclonal antibod-
ies of the biomolecule schematically shown in Figure 1a
in combination with ﬂuorescence optical microscopy Leica.
Flourescence microscopy speciﬁcally detected ﬂuorescence
only from the gold nanopattern and protein functionalized
glass surface, as shown in Figs. 2a–2c, bottom area. Here,
with each sample the dipping edge which is the boundary
between the nanopattern and nonpattern glass surface areas is
shown. The nonpattern surface areas do not show any ﬂuo-
rescence. The area of the nanopattern close to the dipping
boundary usually shows less uniform and more intense ﬂuo-
rescence due to less ordered and denser packed gold nano-
pattern.
While ﬂuorescence microscopy gives information on a
global length scale with respect to the size of individual mol-
ecules or nanostructures, SF and scanning electron SE mi-
croscopies may provide local information on successful site-
speciﬁc functionalization. Figure 3a shows a typical SF
micrograph of a gold nanopattern surface, where the glass
was passivated by PEG and the gold nanoparticles were
functionalized by NTA but with no biomolecules. The re-
spective height plots of the lines shown in the image are
given in Figs. 3b and 3c. The heights of the gold dots are
around 5±0.5 nm. Consideration of an original gold dot
height of 8 nm and a PEG layer of 3 nm covering the glass
area in between the gold dots conﬁrms the experimental data
given. Figure 3d shows a typical SF micrograph of an
N-cadherin functionalized nanopattern. The N-cadherin bio-
functionalized gold dots show a signiﬁcant increase in height
between 12 and 22 nm as indicated by the height plots in
Figs. 3e and 3f. The extracellular domain of N-cadherin
has a reported length of around 20–25 nm in its outstretched
and physiologically active form.26 Taking into account that
the proteins were imaged in their dry state the SF data shown
in Fig. 3 indicate that each gold dot must be successfully
functionalized by at least one biomolecule. Nonfunctional-
ized gold dots were not found for the areas imaged.
In order to prove the functionality and the number of bio-
molecules per single gold nanoparticle, scanning electron
microscopy in combination with immunogold labeling was
applied. Figure 4a shows a representative SE micrograph of
gold nanopattern biofunctionalized with N-cadherin after in-
cubation with the gold labeled secondary antibody only,
without incubation of primary antibodies. The white dots
represent the gold from the nanopattern comparable to a situ-
ation where gold dots are not functionalized by biomol-
ecules. The gold nanoparticles have a diameter of approxi-
mately 8 nm. Similar results were found for agrin data not
shown. No gold conjugated antibodies were observed,
which indicates that unspeciﬁc binding of gold conjugated
antibodies did not occur at the concentrations applied. Also
on the pure PEG passivated surface area no unspeciﬁcally
adsorbed gold conjugated antibody was found. The situation
is very different if the biomolecule functionalized nanostruc-
tures were ﬁrst incubated with the primary antibodies and
then with the gold conjugated secondary antibodies, as given
in Fig. 4b for N-cadherin and in Fig. 4c for agrin. In the
case of N-cadherin 1041 individual Au nanoparticles of the
pattern were analyzed from which 75% were found to be
labeled with one 48% or two 27% additional gold par-
ticles via secondary antibodies at a distance less than 20 nm
from the Au nanoparticle of the pattern. This indicates the
successful binding of NTA-thiol, biomolecule, and primary
and gold conjugated secondary antibodies. The diameter of
the gold particle conjugated to the secondary antibody was
approximately 5 nm and allows its distinction from the gold
pattern which was made of 8 nm large dots. In Fig. 4b,
nearly each gold particle which forms the nanopattern carries
two additional gold particles yellow arrows of 5 nm conju-
gated to the secondary antibody. This is very reasonable
since in this study N-cadherins are homodimeric molecules.
Only 1% of the Au nanoparticle of the pattern carried three
additional nanoparticles. No Au nanoparticles of the pattern
FIG. 2. Flourescence microscopy of a L1, b N-cadherin, and c agrin
immobilized on functionalized gold pattern 30 nm spacing of 8 nm large
gold particles. Depicted is the boundary white arrow which separates the
nanopattern area from the pure PEG passivated glass surface. Scale bar is
50 m for all images.
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were found that carried more than three additional gold par-
ticles. This proves that the size of the Au nanoparticle of the
pattern restricts the number of homodimeric N-cadherin to
up to 1. 24% of the Au nanoparticle of the pattern did not
show additional gold particles to the one presented by the
nanopattern. The reason for this might be manifold.
N-cadherin located on the pattern might not be structurally
active anymore, the secondary antibody did not carry a gold
particle, or the gold particle associated to the secondary an-
tibody was located too close to the Au nanoparticle of the
pattern such that SE microscopy could not resolve it. This
argumentation leads to the conclusion that the successful
binding of functional homodimeric N-cadherin might be sub-
stantially better than the given 75%.
In the case of agrin, detection of two conjugated gold
particles per Au nanoparticle of the pattern Fig. 4c, yellow
FIG. 3. a Scanning force microscopy anaylsis of NTA-thiol functionalized gold nanostructures. b and c display line analysis for these data as indicated
by lines given in the image. d Scanning force microscopy analysis of N-cadherin functionalized gold nanoparticles. e and f show line analysis as indicated
by lines given in d.
FIG. 4. Immunogold SE microscopy for detection of single molecules. a Negative control of N-cadherin functionalized nanopattern does not show unspeciﬁc
binding of gold conjugated secondary antibodies if not treated with primary antibodies ﬁrst. b N-cadherin and c agrin biofunctionalized nanostructures after
incubation with respective monoclonal primary and gold conjugated secondary antibodies. Arrows indicate the location of two yellow arrow and one red
arrow additional gold 5 nm conjugated antibodies close to a gold particle 8 nm which forms the nanopattern. Green arrows indicate location of gold
particles conjugated to secondary antibodies on top of the gold from the nanopattern. These sites do not resolve a second spot but brighter intensity. Note that
N-cadherin b is a homodimer providing two binding site for the monoclonal antibody, while agrin c is a monovalent biomolecule. Scale bar is 100 nm for
all images.
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arrows was found for 57% out of 830 cases. Principally gold
labels conjugated to the secondary antibody seem to be
closer to the Au nanoparticle of the pattern than for
N-cadherin. This is also in consistence with SF-microscopy
results for agrin on nanopatterns, showing less high objects
than those for cadherin data not shown. In a few cases, gold
labels seem to be on top of a gold dot from the pattern since
these dots are stronger in intensity than nonlabeled gold dots
from the pattern Fig. 4c, green arrows. These were also
counted as a successful binding event. However, resolving of
the second gold particle is much harder for agrin patterns
because of the smaller size of the protein which resulted in
38% of the Au nanoparticle of the pattern to appear not la-
beled. Only 5% of the Au nanoparticle of the pattern carried
two gold particles from the antibody. No event was found
where more than two gold particles per pattern dot were
found. Again this proves that the size of the Au nanoparticle
from the pattern restricts the number of functional agrin mol-
ecules up to 1.
IV. CONCLUSION
The results show that up to 75% of gold particles which
form the nanopattern are covered with only a single func-
tional biomolecule, i.e., N-cadherin. The precision given by
such surface concentrations are much higher than in any
other cases reported so far. In addition, the data prove that
the given density is molecularly deﬁned. This is an essential
requirement for the control of functional biomolecule clus-
tering since many biomolecules operate not as individual en-
tities but rather as part of a macromolecular complex. Since
the chemistry for attaching His tags to proteins is very gen-
eral, this approach enables the application of a large number
of different biomolecules oriented in a nanoscaled array.
Such arrays of single biomolecules can be applied in cell
culture studies, presenting a molecularly deﬁned environ-
ment to cell surfaces. Especially transmembrane proteins
with relevance for cell adhesion, survival, and differentiation
are interesting candidates for those substrates. Such nanopat-
tern substrates offer for the ﬁrst time investigations with re-
spect to the function of single molecules arranged in molecu-
larly deﬁned pattern. One can exactly determine the number,
spatial positioning, and orientation of molecules being pre-
sented at the interface.
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